Health Care: Drugs

Dynavax Technologies Corp (DVAX: NASDAQ)

$10.33 n/a | n/a%
09/29/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 4.05M 11.03M 11.25M 9.71M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 4.05M 11.03M 11.25M 9.71M
Selling, General, and Administrative Expenses 22.18M 17.38M 25.94M 28.16M
Research & Development 86.94M 84.58M 50.87M 49.15M
Operating Income before D & A (EBITDA) -105.07M -90.92M -65.56M -67.60M
Depreciation & Amortization 1.91M 2.29M 2.25M 2.50M
Interest Income 205.00K 191.00K 116.00K 291.00K
Other Income - Net -1.35M 433.00K -348.00K -293.00K
Special Income / Charges 0.00 -386.00K -926.00K 0.00
Total Income Before Interest Expenses (EBIT) -108.13M -92.97M -68.97M -70.10M
Interest Expense 572.00K 35.00K 0.00 2.35M
Pre-Tax Income -108.70M -93.01M -68.97M -72.45M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -106.79M -90.72M -66.72M -69.95M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -106.79M -90.72M -66.72M -69.95M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -106.79M -90.72M -66.72M -69.95M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-106.79M -90.34M -65.79M -69.95M
Preferred Dividends
Net Income Available To Common -106.79M -90.72M -75.19M -69.95M
Basic EPS from Continuing Ops. -3.25 -3.45 -3.83 -4.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -3.25 -3.45 -3.83 -4.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.03 0.00
Basic EPS, Total -3.25 -3.45 -3.80 -4.10
Basic Normalized Net Income/Share -3.25 -3.44 -3.78 -4.10
EPS fr Continuing Ops. -3.25 -3.45 -3.83 -4.10
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -3.25 -3.45 -3.83 -4.10
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.03 0.00
EPS, Total -3.25 -3.45 -3.80 -4.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-3.25 -3.44 -3.78 -4.10
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DVAX

Latest DVAX Headlines from TheStreet

More Financial News for DVAX

Press Releases for DVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter